Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Bedenić, B; Sardelić, S; Bogdanić, M; Zarfel, G; Beader, N; Šuto, S; Krilanović, M; Vraneš, J.
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
Arch Microbiol. 2021; 203(4):1825-1831 Doi: 10.1007/s00203-020-02161-x
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Zarfel Gernot
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Recently, emergence of carbapenem-resistance, in particular due to Klebsiella pneumoniae carbapenemase (KPC), was observed among K. pneumoniae causing urinary tract infections in Croatia. The aim of the study was to characterize, antimicrobial susceptibility, carbapenem resistance, virulence traits and plasmid types of the urinary KPC positive isolates of K. pneumoniae. The antimicrobial susceptibility to a wide range of antibiotics was determined by broth microdilution method. The transferability of meropenem resistance was determined by conjugation (broth mating method) employing Escherichia coli J63 strain resistant to sodium azide. Genes encoding broad and extended-spectrum β-lactamases, plasmid-mediated AmpC β-lactamases, group A and B carbapenemases, and carbapenem hydrolyzing oxacillinases (blaOXA-48like), respectively, were determined by Polymerase chain reaction (PCR). In total 30 KPC-positive K. pneumoniae urinary isolates collected from different regions of Croatia were analysed. The isolates were uniformly resistant to all tested antibiotics except for variable susceptibility to gentamicin, sulphamethoxazole/trimethoprim, and colistin, respectively. Four isolates were resistant to colistin with MICs values ranging from 4 to 16 mg/L. All tested isolates were susceptible to ceftazidime/avibactam. Sixteen isolates transferred meropenem resistance to E. coli recipient strain by conjugation. Other resistance markers were not co-transferred. PCR was positive for blaKPC and blaSHV genes in all isolates whereas 13 isolates tested positive also for blaTEM genes. PCR based replicon typing (PBRT) revealed the presence of FIIs in 13 and FIA plasmid in two strains. The study showed dissemination of KPC-producing K. pneumoniae in urinary isolates, posing a new epidemiological and treatment challenge. Sulphamethoxazole/trimethoprim, colistin, and ceftazidime/avibactam remain so far, as the therapeutic options.
Find related publications in this database (using NLM MeSH Indexing)
Anti-Bacterial Agents - pharmacology
Azabicyclo Compounds - pharmacology
Bacterial Proteins - genetics
Carbapenem-Resistant Enterobacteriaceae - genetics, metabolism
Ceftazidime - pharmacology
Croatia - administration & dosage
Drug Combinations - administration & dosage
Escherichia coli - genetics
Humans - administration & dosage
Klebsiella Infections - drug therapy, microbiology
Klebsiella pneumoniae - drug effects, genetics, metabolism
Meropenem - pharmacology
Microbial Sensitivity Tests - administration & dosage
Plasmids - genetics
Urinary Tract Infections - drug therapy, microbiology
beta-Lactamases - genetics

Find related publications in this database (Keywords)
Klebsiella pneumoniae
KPC
Urinary tract infections
Resistance
© Med Uni GrazImprint